ArticleJournal for immunotherapy of cancer2022

High-affinity CD16 integration into a CRISPR/Cas9-edited CD38 locus augments CD38-directed antitumor activity of primary human natural killer cells.

Joseph Andrew Clara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.